Delivery Order SPE2DB20D3103-SPE2DB21FP7Y3

Award Date 8/5/21
Potential Completion Date 8/6/21
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment, 15 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,003.73, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 10, 2023, with a completion date of May 11, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 15 gram tubes of hydrocortisone valerate 0.2% ointment. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $2,939.33. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 17, 2023. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award, valued at $1,013.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Hydrocortisone Valerate 0.2% Ointment, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 15, 2023. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.83, is for the delivery of Hydrocortisone Valerate 0.2% Ointment, a topical steroid medication. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.85 firm-fixed-price contract is for the delivery of 4556497960 - Hydrocortisone Valerate 0.2% Ointment, 45g tubes. The award has no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FABZ8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566280744 - Hydrocortisone Valerate 0.2% Ointment, 15 grams, with a ceiling value of $1,172.85 and a period of performance through October 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Hydrocortisone Val 0.2% Ointment, 15 grams, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc., for a ceiling value of $2,806.26. The contract has a completion date of February 8, 2024, and is a delivery order under a Firm Fixed Price contract type. The award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567642981 - Hydrocortisone Valerate 0.2% Ointment 15GM. The firm-fixed-price contract has a ceiling value of $2,886.69 and a performance period through March 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566868256 - Hydrocortisone Valerate 0.2% Ointment, 60 grams. The delivery order has a ceiling value of $4,604.01 and a completion date of January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,976.23 firm-fixed-price delivery order is for the supply of 15 gram tubes of 0.2% hydrocortisone ointment. The award has an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP7Y3
    Delivery Order

This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment in 45 gram tubes. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2021. The contract is a Delivery Order with a Firm Fixed Price of $3,348.76 and has an Ultimate Completion Date of August 6, 2021. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies.

Generated 2/27/25, 12:24 PM